Literature DB >> 2080857

Prolactin and growth hormone: molecular heterogeneity and measurement in serum.

C R Smith1, M R Norman.   

Abstract

The pituitary hormones prolactin and growth hormone are related single-chain polypeptides. Both hormones exist in the circulation in several molecular forms, and this heterogeneity may account for some of the complex and sometimes contradictory actions, in vivo and in vitro, of both hormones. It may also lead to problems with quantitation by immunoassays and discrepancies between the results given by assays using different antibodies. Modified forms of the hormones may have markedly different activity in bioassays from that of the parent hormone, but the clinical significance of this is unclear. In this review we summarize what is known about the molecular heterogeneity of the hormones and briefly discuss the implications for clinical biochemists.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080857     DOI: 10.1177/000456329002700604

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Three cases of macroprolactinaemia.

Authors:  A O Olukoga; T L Dornan; J W Kane
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

2.  Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

Authors:  R ElMazoudy; N AbdelHameed; A ElMasry
Journal:  Int J Impot Res       Date:  2015-09-24       Impact factor: 2.896

3.  Clinical and radiological findings in macroprolactinemia.

Authors:  Serhat Isik; Dilek Berker; Yasemin Ates Tutuncu; Ufuk Ozuguz; Ferhat Gokay; Gonul Erden; Hatice Nursun Ozcan; Ferit Kerim Kucukler; Yusuf Aydin; Serdar Guler
Journal:  Endocrine       Date:  2011-12-21       Impact factor: 3.633

4.  Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.

Authors:  John F Langenheim; Dunyong Tan; Ameae M Walker; Wen Y Chen
Journal:  Mol Endocrinol       Date:  2005-11-03

5.  Identification of IgG-immunocomplex macroprolactin with an immunometric "sandwich" system: technical and clinical considerations.

Authors:  P Amadori; C Dilberis; A Marcolla; M Pinamonti; P Menapace; A Valentini
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

6.  Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.

Authors:  P Amadori; C Dilberis; A Marcolla; M Pinamonti; P Menapace; F Dal Bosco
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

7.  Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.

Authors:  M Guitelman; M E Colombani-Vidal; C C Zylbersztein; L Fiszlejder; M Zeller; O Levalle; H E Scaglia
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

8.  Macroprolactinemia: the consequences of a laboratory pitfall.

Authors:  Erzsébet Toldy; Zoltán Löcsei; István Szabolcs; Miklós I Góth; Pál Kneffel; Dominika Szöke; Gábor L Kovács
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.